White House pushes for oversight of Columbia University
The Trump administration is considering placing the school under a consent decree


What happened
The Trump administration is seeking to lock Columbia University into a legally binding consent decree, giving the White House oversight of the university for years to come, The Wall Street Journal said Thursday. The proposal is a significant escalation of President Donald Trump's expanding effort to exert power over top-tier U.S. universities by withholding federal research funds.
Who said what
After Trump withheld $400 million in grants and contracts to Columbia, accusing the school of insufficiently protecting Jewish students from harassment during 2024 Gaza War protests, the university "agreed to an initial set of demands," the Journal said. A consent decree would legally bind Columbia to those and future concessions, giving a judge the power to levy fines for noncompliance.
The Trump administration calls its cancellation of research funds and foreign student visas a "campaign against antisemitism on college campuses," The Associated Press said. Critics call it a "crackdown on free speech" and academic freedom.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
What next?
A consent decree with Columbia "could serve as a model for other schools seeking to negotiate with the White House," The New York Times said. But the university would have to agree, and negotiations "could require an extended process." Judges "can't just wave a wand and turn an agreement into a consent decree absent a lawsuit," said University of Pennsylvania law professor Tobias Wolff.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Rafi Schwartz has worked as a politics writer at The Week since 2022, where he covers elections, Congress and the White House. He was previously a contributing writer with Mic focusing largely on politics, a senior writer with Splinter News, a staff writer for Fusion's news lab, and the managing editor of Heeb Magazine, a Jewish life and culture publication. Rafi's work has appeared in Rolling Stone, GOOD and The Forward, among others.
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
The Secret Service is reportedly facing a massive sniper shortage
The Explainer The agency is reportedly dealing with a 73% shortage
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
DC sues Trump to end Guard 'occupation'
Speed Read D.C. Attorney General Brian Schwalb argues that the unsolicited military presence violates the law
-
RFK Jr. faces bipartisan heat in Senate hearing
Speed Read The health secretary defended his leadership amid CDC turmoil and deflected questions about the restricted availability of vaccines
-
White House defends boat strike as legal doubts mount
Speed Read Experts say there was no legal justification for killing 11 alleged drug-traffickers
-
Can US tourism survive Trump's policies?
Today's Big Question The tourist economy is 'heading in the wrong direction'
-
Epstein accusers urge full file release, hint at own list
speed read A rally was organized by Reps. Ro Khanna and Thomas Massie, who are hoping to force a vote on their Epstein Files Transparency Act
-
Court hands Harvard a win in Trump funding battle
Speed Read The Trump administration was ordered to restore Harvard's $2 billion in research grants
-
Florida aims to end all state vaccine requirements
Speed Read Health Secretary Robert F. Kennedy Jr. continues to cut vaccine access and install anti-vaccine activists at the FDA and CDC
-
Why reports of Donald Trump's demise are greatly exaggerated
In The Spotlight US president has once again brushed aside rumours that he's dead